Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/07/23 → 30/06/26 |
Funding
- United States Department of Defense (DOD): A$577,409.42
- US Army Medical Research Acquisition Activity
Interferon epsilon: a new localised immunotherapy for ovarian cancer
- Campbell, Nicole (Primary Chief Investigator (PCI))
- Hertzog, Paul (Chief Investigator (CI))
- Ho, Gwo-Yaw (Chief Investigator (CI))
Project: Research